The role of immunosuppression and immune‐activation in classic Kaposi's sarcoma

Immunodeficiency and elevated levels of cytokines have been associated with the development of Kaposi's sarcoma (KS) lesions in patients with AIDS and iatrogenic immunodeficiency. However, their role in classic KS (CKS) is unclear. We measured peripheral blood cell levels, including T‐cell subs...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cancer 1999-09, Vol.82 (6), p.817-821
Hauptverfasser: Touloumi, Giota, Hatzakis, Angelos, Potouridou, Irini, Milona, Ioanna, Strarigos, John, Katsambas, Andreas, Giraldo, Gaetano, Beth‐Giraldo, Elke, Biggar, Robert J., Mueller, Nancy, Trichopoulos, Dimitrios
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 821
container_issue 6
container_start_page 817
container_title International journal of cancer
container_volume 82
creator Touloumi, Giota
Hatzakis, Angelos
Potouridou, Irini
Milona, Ioanna
Strarigos, John
Katsambas, Andreas
Giraldo, Gaetano
Beth‐Giraldo, Elke
Biggar, Robert J.
Mueller, Nancy
Trichopoulos, Dimitrios
description Immunodeficiency and elevated levels of cytokines have been associated with the development of Kaposi's sarcoma (KS) lesions in patients with AIDS and iatrogenic immunodeficiency. However, their role in classic KS (CKS) is unclear. We measured peripheral blood cell levels, including T‐cell subsets, as well as neopterin and β2‐microglobulin in 91 HIV‐negative Greek patients with histologically confirmed CKS and in 107 controls matched for age and sex. CKS cases had slightly lower leukocyte counts (p = 0.08) and lymphocyte counts (p = 0.02). Although the percentage of CD4 and CD8 T‐lymphocytes were not significantly different from controls (p = 0.10 and p = 0.45, respectively), CD4 T‐lymphocytes were lower in cases than controls (812 cells/μL and 1,009 cells/μL, respectively; p = 0.01); part of this difference resulted from the lower lymphocyte counts (p = 0.07 after adjusting for lymphocyte counts). However, neopterin and β2‐microglobulin were both considerably elevated [geometric mean (95% CI): 8.35 (7.27–9.73) nmol/L and 2,904 (2,479–3,401) μg/L in cases and 5.86 (5.40–6.35) nmol/L and 2,042 (1,880–2,218) μg/L in controls, respectively]. We conclude that CKS patients are predominantly characterised by immune activation, although an element of minor immunosupression may also be present. Int. J. Cancer 82:817–821, 1999. © 1999 Wiley‐Liss, Inc.
doi_str_mv 10.1002/(SICI)1097-0215(19990909)82:6<817::AID-IJC8>3.0.CO;2-7
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69967074</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69967074</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4728-8db869ffe4de0893fa06f611b0b50326e57e901d2f4a5d0f76e5dd8655426ede3</originalsourceid><addsrcrecordid>eNqFkN1qFDEYhoModq3egsyBaHsw65eZTDLZSqGMf6OFRayefmTzgyPzZ7LT0jMvwWv0Ssy4qxUUJAchX568vHkIOaWwpADZ06P3dVUfU5AihYwWR1RKCXEdl9mKPyupWK3O6udp_aYqT_MlLKv1SZaKW2Tx-8ltsohBkAqa8wNyL4TPAJQWwO6SAwqMccbEgry7-GQTP7Q2GVzSdN3UD2EaR29DaIY-Ub3ZTe33r9-U3jaXajvPmz7RrYqMTt6qcQjNk5AE5fXQqfvkjlNtsA_2-yH58PLFRfU6PV-_qquz81QzkZVpaTYll85ZZiyUMncKuOOUbmBTQJ5xWwgrgZrMMVUYcCJOjCl5UbB4aWx-SB7vckc_fJls2GLXBG3bVvV2mAJyKbkAwSL4cQdqP4TgrcPRN53y10gBZ9mIs2yczeFsDn_JxjJDjlE2YpSNs2zMEbBaY4YiBj_cN5g2nTV_xO7sRuDRHlBBq9Z51esm3HCSFvHnNwWvmtZe_9Xuv-X-0e3nOf8BaRCn3w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69967074</pqid></control><display><type>article</type><title>The role of immunosuppression and immune‐activation in classic Kaposi's sarcoma</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Touloumi, Giota ; Hatzakis, Angelos ; Potouridou, Irini ; Milona, Ioanna ; Strarigos, John ; Katsambas, Andreas ; Giraldo, Gaetano ; Beth‐Giraldo, Elke ; Biggar, Robert J. ; Mueller, Nancy ; Trichopoulos, Dimitrios</creator><creatorcontrib>Touloumi, Giota ; Hatzakis, Angelos ; Potouridou, Irini ; Milona, Ioanna ; Strarigos, John ; Katsambas, Andreas ; Giraldo, Gaetano ; Beth‐Giraldo, Elke ; Biggar, Robert J. ; Mueller, Nancy ; Trichopoulos, Dimitrios</creatorcontrib><description>Immunodeficiency and elevated levels of cytokines have been associated with the development of Kaposi's sarcoma (KS) lesions in patients with AIDS and iatrogenic immunodeficiency. However, their role in classic KS (CKS) is unclear. We measured peripheral blood cell levels, including T‐cell subsets, as well as neopterin and β2‐microglobulin in 91 HIV‐negative Greek patients with histologically confirmed CKS and in 107 controls matched for age and sex. CKS cases had slightly lower leukocyte counts (p = 0.08) and lymphocyte counts (p = 0.02). Although the percentage of CD4 and CD8 T‐lymphocytes were not significantly different from controls (p = 0.10 and p = 0.45, respectively), CD4 T‐lymphocytes were lower in cases than controls (812 cells/μL and 1,009 cells/μL, respectively; p = 0.01); part of this difference resulted from the lower lymphocyte counts (p = 0.07 after adjusting for lymphocyte counts). However, neopterin and β2‐microglobulin were both considerably elevated [geometric mean (95% CI): 8.35 (7.27–9.73) nmol/L and 2,904 (2,479–3,401) μg/L in cases and 5.86 (5.40–6.35) nmol/L and 2,042 (1,880–2,218) μg/L in controls, respectively]. We conclude that CKS patients are predominantly characterised by immune activation, although an element of minor immunosupression may also be present. Int. J. Cancer 82:817–821, 1999. © 1999 Wiley‐Liss, Inc.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/(SICI)1097-0215(19990909)82:6&lt;817::AID-IJC8&gt;3.0.CO;2-7</identifier><identifier>PMID: 10446447</identifier><identifier>CODEN: IJCNAW</identifier><language>eng</language><publisher>New York: John Wiley &amp; Sons, Inc</publisher><subject>AIDS/HIV ; beta 2-Microglobulin - analysis ; Biological and medical sciences ; Biomarkers - blood ; Case-Control Studies ; CD4 Lymphocyte Count ; CD4-Positive T-Lymphocytes - immunology ; CD8-Positive T-Lymphocytes - immunology ; Dermatology ; Female ; Greece ; Hematocrit ; HIV Seronegativity ; Humans ; Leukocyte Count ; Lymphocyte Count ; Male ; Medical sciences ; Neopterin - blood ; Reference Values ; Sarcoma, Kaposi - blood ; Sarcoma, Kaposi - immunology ; Sarcoma, Kaposi - pathology ; Skin Neoplasms - blood ; Skin Neoplasms - immunology ; Skin Neoplasms - pathology ; T-Lymphocyte Subsets - immunology ; Tumors of the skin and soft tissue. Premalignant lesions</subject><ispartof>International journal of cancer, 1999-09, Vol.82 (6), p.817-821</ispartof><rights>Copyright © 1999 Wiley‐Liss, Inc.</rights><rights>1999 INIST-CNRS</rights><rights>Copyright 1999 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c4728-8db869ffe4de0893fa06f611b0b50326e57e901d2f4a5d0f76e5dd8655426ede3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291097-0215%2819990909%2982%3A6%3C817%3A%3AAID-IJC8%3E3.0.CO%3B2-7$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291097-0215%2819990909%2982%3A6%3C817%3A%3AAID-IJC8%3E3.0.CO%3B2-7$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1915893$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10446447$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Touloumi, Giota</creatorcontrib><creatorcontrib>Hatzakis, Angelos</creatorcontrib><creatorcontrib>Potouridou, Irini</creatorcontrib><creatorcontrib>Milona, Ioanna</creatorcontrib><creatorcontrib>Strarigos, John</creatorcontrib><creatorcontrib>Katsambas, Andreas</creatorcontrib><creatorcontrib>Giraldo, Gaetano</creatorcontrib><creatorcontrib>Beth‐Giraldo, Elke</creatorcontrib><creatorcontrib>Biggar, Robert J.</creatorcontrib><creatorcontrib>Mueller, Nancy</creatorcontrib><creatorcontrib>Trichopoulos, Dimitrios</creatorcontrib><title>The role of immunosuppression and immune‐activation in classic Kaposi's sarcoma</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Immunodeficiency and elevated levels of cytokines have been associated with the development of Kaposi's sarcoma (KS) lesions in patients with AIDS and iatrogenic immunodeficiency. However, their role in classic KS (CKS) is unclear. We measured peripheral blood cell levels, including T‐cell subsets, as well as neopterin and β2‐microglobulin in 91 HIV‐negative Greek patients with histologically confirmed CKS and in 107 controls matched for age and sex. CKS cases had slightly lower leukocyte counts (p = 0.08) and lymphocyte counts (p = 0.02). Although the percentage of CD4 and CD8 T‐lymphocytes were not significantly different from controls (p = 0.10 and p = 0.45, respectively), CD4 T‐lymphocytes were lower in cases than controls (812 cells/μL and 1,009 cells/μL, respectively; p = 0.01); part of this difference resulted from the lower lymphocyte counts (p = 0.07 after adjusting for lymphocyte counts). However, neopterin and β2‐microglobulin were both considerably elevated [geometric mean (95% CI): 8.35 (7.27–9.73) nmol/L and 2,904 (2,479–3,401) μg/L in cases and 5.86 (5.40–6.35) nmol/L and 2,042 (1,880–2,218) μg/L in controls, respectively]. We conclude that CKS patients are predominantly characterised by immune activation, although an element of minor immunosupression may also be present. Int. J. Cancer 82:817–821, 1999. © 1999 Wiley‐Liss, Inc.</description><subject>AIDS/HIV</subject><subject>beta 2-Microglobulin - analysis</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Case-Control Studies</subject><subject>CD4 Lymphocyte Count</subject><subject>CD4-Positive T-Lymphocytes - immunology</subject><subject>CD8-Positive T-Lymphocytes - immunology</subject><subject>Dermatology</subject><subject>Female</subject><subject>Greece</subject><subject>Hematocrit</subject><subject>HIV Seronegativity</subject><subject>Humans</subject><subject>Leukocyte Count</subject><subject>Lymphocyte Count</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neopterin - blood</subject><subject>Reference Values</subject><subject>Sarcoma, Kaposi - blood</subject><subject>Sarcoma, Kaposi - immunology</subject><subject>Sarcoma, Kaposi - pathology</subject><subject>Skin Neoplasms - blood</subject><subject>Skin Neoplasms - immunology</subject><subject>Skin Neoplasms - pathology</subject><subject>T-Lymphocyte Subsets - immunology</subject><subject>Tumors of the skin and soft tissue. Premalignant lesions</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkN1qFDEYhoModq3egsyBaHsw65eZTDLZSqGMf6OFRayefmTzgyPzZ7LT0jMvwWv0Ssy4qxUUJAchX568vHkIOaWwpADZ06P3dVUfU5AihYwWR1RKCXEdl9mKPyupWK3O6udp_aYqT_MlLKv1SZaKW2Tx-8ltsohBkAqa8wNyL4TPAJQWwO6SAwqMccbEgry7-GQTP7Q2GVzSdN3UD2EaR29DaIY-Ub3ZTe33r9-U3jaXajvPmz7RrYqMTt6qcQjNk5AE5fXQqfvkjlNtsA_2-yH58PLFRfU6PV-_qquz81QzkZVpaTYll85ZZiyUMncKuOOUbmBTQJ5xWwgrgZrMMVUYcCJOjCl5UbB4aWx-SB7vckc_fJls2GLXBG3bVvV2mAJyKbkAwSL4cQdqP4TgrcPRN53y10gBZ9mIs2yczeFsDn_JxjJDjlE2YpSNs2zMEbBaY4YiBj_cN5g2nTV_xO7sRuDRHlBBq9Z51esm3HCSFvHnNwWvmtZe_9Xuv-X-0e3nOf8BaRCn3w</recordid><startdate>19990909</startdate><enddate>19990909</enddate><creator>Touloumi, Giota</creator><creator>Hatzakis, Angelos</creator><creator>Potouridou, Irini</creator><creator>Milona, Ioanna</creator><creator>Strarigos, John</creator><creator>Katsambas, Andreas</creator><creator>Giraldo, Gaetano</creator><creator>Beth‐Giraldo, Elke</creator><creator>Biggar, Robert J.</creator><creator>Mueller, Nancy</creator><creator>Trichopoulos, Dimitrios</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19990909</creationdate><title>The role of immunosuppression and immune‐activation in classic Kaposi's sarcoma</title><author>Touloumi, Giota ; Hatzakis, Angelos ; Potouridou, Irini ; Milona, Ioanna ; Strarigos, John ; Katsambas, Andreas ; Giraldo, Gaetano ; Beth‐Giraldo, Elke ; Biggar, Robert J. ; Mueller, Nancy ; Trichopoulos, Dimitrios</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4728-8db869ffe4de0893fa06f611b0b50326e57e901d2f4a5d0f76e5dd8655426ede3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>AIDS/HIV</topic><topic>beta 2-Microglobulin - analysis</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Case-Control Studies</topic><topic>CD4 Lymphocyte Count</topic><topic>CD4-Positive T-Lymphocytes - immunology</topic><topic>CD8-Positive T-Lymphocytes - immunology</topic><topic>Dermatology</topic><topic>Female</topic><topic>Greece</topic><topic>Hematocrit</topic><topic>HIV Seronegativity</topic><topic>Humans</topic><topic>Leukocyte Count</topic><topic>Lymphocyte Count</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neopterin - blood</topic><topic>Reference Values</topic><topic>Sarcoma, Kaposi - blood</topic><topic>Sarcoma, Kaposi - immunology</topic><topic>Sarcoma, Kaposi - pathology</topic><topic>Skin Neoplasms - blood</topic><topic>Skin Neoplasms - immunology</topic><topic>Skin Neoplasms - pathology</topic><topic>T-Lymphocyte Subsets - immunology</topic><topic>Tumors of the skin and soft tissue. Premalignant lesions</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Touloumi, Giota</creatorcontrib><creatorcontrib>Hatzakis, Angelos</creatorcontrib><creatorcontrib>Potouridou, Irini</creatorcontrib><creatorcontrib>Milona, Ioanna</creatorcontrib><creatorcontrib>Strarigos, John</creatorcontrib><creatorcontrib>Katsambas, Andreas</creatorcontrib><creatorcontrib>Giraldo, Gaetano</creatorcontrib><creatorcontrib>Beth‐Giraldo, Elke</creatorcontrib><creatorcontrib>Biggar, Robert J.</creatorcontrib><creatorcontrib>Mueller, Nancy</creatorcontrib><creatorcontrib>Trichopoulos, Dimitrios</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Touloumi, Giota</au><au>Hatzakis, Angelos</au><au>Potouridou, Irini</au><au>Milona, Ioanna</au><au>Strarigos, John</au><au>Katsambas, Andreas</au><au>Giraldo, Gaetano</au><au>Beth‐Giraldo, Elke</au><au>Biggar, Robert J.</au><au>Mueller, Nancy</au><au>Trichopoulos, Dimitrios</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of immunosuppression and immune‐activation in classic Kaposi's sarcoma</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>1999-09-09</date><risdate>1999</risdate><volume>82</volume><issue>6</issue><spage>817</spage><epage>821</epage><pages>817-821</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><coden>IJCNAW</coden><abstract>Immunodeficiency and elevated levels of cytokines have been associated with the development of Kaposi's sarcoma (KS) lesions in patients with AIDS and iatrogenic immunodeficiency. However, their role in classic KS (CKS) is unclear. We measured peripheral blood cell levels, including T‐cell subsets, as well as neopterin and β2‐microglobulin in 91 HIV‐negative Greek patients with histologically confirmed CKS and in 107 controls matched for age and sex. CKS cases had slightly lower leukocyte counts (p = 0.08) and lymphocyte counts (p = 0.02). Although the percentage of CD4 and CD8 T‐lymphocytes were not significantly different from controls (p = 0.10 and p = 0.45, respectively), CD4 T‐lymphocytes were lower in cases than controls (812 cells/μL and 1,009 cells/μL, respectively; p = 0.01); part of this difference resulted from the lower lymphocyte counts (p = 0.07 after adjusting for lymphocyte counts). However, neopterin and β2‐microglobulin were both considerably elevated [geometric mean (95% CI): 8.35 (7.27–9.73) nmol/L and 2,904 (2,479–3,401) μg/L in cases and 5.86 (5.40–6.35) nmol/L and 2,042 (1,880–2,218) μg/L in controls, respectively]. We conclude that CKS patients are predominantly characterised by immune activation, although an element of minor immunosupression may also be present. Int. J. Cancer 82:817–821, 1999. © 1999 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>10446447</pmid><doi>10.1002/(SICI)1097-0215(19990909)82:6&lt;817::AID-IJC8&gt;3.0.CO;2-7</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0020-7136
ispartof International journal of cancer, 1999-09, Vol.82 (6), p.817-821
issn 0020-7136
1097-0215
language eng
recordid cdi_proquest_miscellaneous_69967074
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects AIDS/HIV
beta 2-Microglobulin - analysis
Biological and medical sciences
Biomarkers - blood
Case-Control Studies
CD4 Lymphocyte Count
CD4-Positive T-Lymphocytes - immunology
CD8-Positive T-Lymphocytes - immunology
Dermatology
Female
Greece
Hematocrit
HIV Seronegativity
Humans
Leukocyte Count
Lymphocyte Count
Male
Medical sciences
Neopterin - blood
Reference Values
Sarcoma, Kaposi - blood
Sarcoma, Kaposi - immunology
Sarcoma, Kaposi - pathology
Skin Neoplasms - blood
Skin Neoplasms - immunology
Skin Neoplasms - pathology
T-Lymphocyte Subsets - immunology
Tumors of the skin and soft tissue. Premalignant lesions
title The role of immunosuppression and immune‐activation in classic Kaposi's sarcoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T15%3A02%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20immunosuppression%20and%20immune%E2%80%90activation%20in%20classic%20Kaposi's%20sarcoma&rft.jtitle=International%20journal%20of%20cancer&rft.au=Touloumi,%20Giota&rft.date=1999-09-09&rft.volume=82&rft.issue=6&rft.spage=817&rft.epage=821&rft.pages=817-821&rft.issn=0020-7136&rft.eissn=1097-0215&rft.coden=IJCNAW&rft_id=info:doi/10.1002/(SICI)1097-0215(19990909)82:6%3C817::AID-IJC8%3E3.0.CO;2-7&rft_dat=%3Cproquest_cross%3E69967074%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69967074&rft_id=info:pmid/10446447&rfr_iscdi=true